| Neptune Technologies & Bioressources Inc. Appoints Former Danone Canada CEO Thierry Houillion to Board of Directors |
| Tuesday, September 26 2006 | |||
Neptune Technologies & Bioressources Inc. Appoints Former Danone Canada CEO Thierry Houillion to Board of DirectorsLAVAL, QC, Sept. 26 /CNW/ - Neptune Technologies & Bioressources Inc., (TSX.V: NTB), "Neptune" is pleased to announce it has appointed Mr. Thierry Houillion to the Board of Directors. This brings the number of Directors on Neptune's Board to six with five independent members. Neptune believes Mr. Houillion will complement and diversify the composition of the Board. "Mr. Houillion's knowledge, experience and vision will timely contribute to Neptune's penetration of the functional food industry. We are very excited to add him to the team," said Mr. Henri Harland, President & CEO of Neptune. About Thierry Houillion: Mr. Houillion holds a Scientific Baccalaureate from Belfort, France, a Degree from the International Commerce Academy in Paris, France and a Master's in Finance from Paris-Dauphine University. In conjunction with the board appointment, Mr. Houillion will be granted 40,000 stock options at $3.00 for a 5-year term. The options will vest over 2 years. These securities have been allocated by Neptune to facilitate commitment, compensation, and alignment with shareholder interests. About Neptune Technologies & Bioressources Inc. https://www.neptunebiotech.com Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets. Neptune Technologies and Acasti Pharma Contact:
Neptune Technologies & Bioressources Inc. Acasti Pharma Inc. Toni Rinow, Ph.D., MBA Corporate Development & Investor Relations (450) 687-2262 This e-mail address is being protected from spambots, you need JavaScript enabled to view it
|